Medication info

Emma O 5% Cream

Prescription medicationCream
Ingredient · strength
Lidocaine›25mg / 1gPrilocaine›25mg / 1g
Manufacturer / importer
Allyco Pharmaceutical Co., Ltd.
Appearance
White cream formulation
Packaging
450g/bottle
Approval status
Active

MFDS item code 200110046 · Notified 2001.02.15

Summary

Main use
Pain relief through surface anesthesia of the skin, genital mucosa, and leg ulcers
Who uses it
Adults · Children
Adult dosage
○ Adults 1. Skin: After applying this drug, cover with an occlusive dressing. Occlusion of the application site should generally be maintained for 1-3 hours, and the effect persists for at least 1 hour after removal of the occlusive dressing. 1) For needle insertion (e.g., intravenous cannulation, blood sampling), apply approximately 2g of this drug for at least 1 hour and up to 5 hours. 2) For minor superficial surgery [e.g., removal of molluscum contagiosum], apply 1.5-2g/10cm2 for 1 hour. 3) For major superficial surgery (e.g., split-thickness skin grafting), apply 1.5-2g/10cm2 for at least 2 hours and up to 5 hours. 2. Genital mucosa: For removal of condylomata, apply approximately 5~10g of this drug to the treatment site for 5-10 minutes, then remove the drug and begin the procedure immediately. 3. Leg ulcers: After applying this drug, cover with an occlusive dressing. Use an opened tube for a single application and discard any remaining cream after each procedure. Apply 1~2g/10cm2 for at least 30 minutes; do not exceed 10g for each treatment. For leg ulcers with tissue that is difficult to penetrate, the application time may be extended to 60 minutes. Cleanse the ulcer within 10 minutes after removing the cream. There was no decrease in efficacy or increase in local reactions when used up to 15 times over 1~2 months.
Children's dosage
○ Infants 3 months-12 months: Total amount 2g; do not exceed an application area of 16cm<sup>2</sup>.

Ingredients

Manufacturer
Allyco Pharmaceutical Co., Ltd.

Efficacy & effects

Pain relief through surface anesthesia of the skin, genital mucosa, and leg ulcers

  • Surface anesthesia of the skin
  • surface anesthesia of the genital mucosa
  • surface anesthesia of leg ulcers
View approved original text

This medication is used for surface anesthesia of the skin during the insertion of a needle or superficial surgical procedures. It is also effective for surface anesthesia of the genital mucosa, such as prior to the removal of condylomas. Furthermore, it aids in surface anesthesia of the skin when removing fibrin, pus, and necrotic tissue prior to washing or superficial surgery, particularly for leg ulcers. It supports comfortable treatment by reducing pain in the skin and mucous membranes in various situations. It is primarily used for surface anesthesia of the skin and mucous membranes.

Dosage and Administration

Adult dosage

○ Adults 1. Skin: After applying this drug, cover with an occlusive dressing. Occlusion of the application site should generally be maintained for 1-3 hours, and the effect persists for at least 1 hour after removal of the occlusive dressing. 1) For needle insertion (e.g., intravenous cannulation, blood sampling), apply approximately 2g of this drug for at least 1 hour and up to 5 hours. 2) For minor superficial surgery [e.g., removal of molluscum contagiosum], apply 1.5-2g/10cm2 for 1 hour. 3) For major superficial surgery (e.g., split-thickness skin grafting), apply 1.5-2g/10cm2 for at least 2 hours and up to 5 hours. 2. Genital mucosa: For removal of condylomata, apply approximately 5~10g of this drug to the treatment site for 5-10 minutes, then remove the drug and begin the procedure immediately. 3. Leg ulcers: After applying this drug, cover with an occlusive dressing. Use an opened tube for a single application and discard any remaining cream after each procedure. Apply 1~2g/10cm2 for at least 30 minutes; do not exceed 10g for each treatment. For leg ulcers with tissue that is difficult to penetrate, the application time may be extended to 60 minutes. Cleanse the ulcer within 10 minutes after removing the cream. There was no decrease in efficacy or increase in local reactions when used up to 15 times over 1~2 months.

Children's dosage

○ Infants 3 months-12 months: Total amount 2g; do not exceed an application area of 16cm<sup>2</sup>.

Precautions

This medication is used as a local anesthetic and may cause a rare blood disorder called methemoglobinemia. Patients with glucose-6-phosphate dehydrogenase deficiency, congenital methemoglobinemia, heart or lung damage, and infants under 6 months old are particularly sensitive to this condition, hence caution is required. This medication should not be used in patients allergic to the ingredients or amide-type local anesthetics, in areas with wounds or dermatitis, in infants under 3 months old, or in premature infants. Patients with anemia or liver disease, elderly patients, and frail patients should use this medication cautiously, and those with allergies to propylene glycol included in this medication should also be cautious. Topical application may cause temporary pallor, redness, swelling, mild initial burning sensation, itching, paresthesia, skin irritation, or corneal irritation. Rarely, allergic reactions or severe cases of anaphylactic shock can occur. It is important to avoid contact with the eyes or ears, and if contact occurs, they should be rinsed immediately as it may cause irritation and damage. The risk of methemoglobinemia may increase when used with other medications, so consultation with healthcare professionals is required when used with other local anesthetics or certain antibiotics and anticancer drugs. There have been no reported risks to the fetus during pregnancy, but the benefits and risks should be carefully considered when used, and caution is necessary during breastfeeding. It is recommended to use this medication in children, especially infants under 3 months, with restrictions and to avoid use on the genital mucosa. In case of overdose, side effects may occur in the central nervous system and cardiovascular system, and immediate medical attention should be sought. The absorption rate of this medication may vary depending on the skin condition or application area, so appropriate dosages and times should be followed as per medical guidance. Long-term high-dose use should be avoided due to experimental results in animals indicating potential carcinogenicity.

Side effects

  • Pallor
  • erythema
  • edema
  • mild initial burning sensation
  • pruritus
  • purpura
  • petechiae
  • methemoglobinemia
  • allergic reactions
  • anaphylactic shock
Show 3 more
  • corneal irritation
  • paresthesia
  • skin irritation

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, and at room temperature between 1°C and 30°C. Proper storage helps maintain the effectiveness of the medication for an extended period.

Appearance and packaging

Appearance

White cream formulation

Package unit

450g/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.